|
|
- 2017
5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-AnalysisKeywords: dutasteride, finasteride, benign prostatic hyperplasia, benign prostatic hypertrophy, 5α-reductase inhibitors dutastéride, finastéride, hyperplasie bénigne de la prostate, hypertrophie bénigne de la prostate, inhibiteurs de l’enzyme 5 alpha-réductase Abstract: Finasteride and dutasteride are competitive inhibitors of 5α-reductase enzymes and are commonly used to treat symptomatic benign prostatic hyperplasia (BPH)
|
